NCT00769093View on ClinicalTrials.gov

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Brain Neoplasms
Interventions
DRUG

Ferumoxytol

2 mg/kg

Trial Locations (1)

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

OHSU Knight Cancer Institute

OTHER